Trials / Conditions / Warm Autoimmune Hemolytic Anemia (wAIHA)
Warm Autoimmune Hemolytic Anemia (wAIHA)
6 registered clinical trials studyying Warm Autoimmune Hemolytic Anemia (wAIHA).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anem NCT05648968 | Novartis Pharmaceuticals | Phase 3 |
| Terminated | Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia NCT05073458 | Incyte Corporation | Phase 3 |
| Active Not Recruiting | Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIH NCT05002777 | Sanofi | Phase 2 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hem NCT04691570 | Annexon, Inc. | Phase 2 |
| Terminated | Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Ane NCT04661033 | Sanofi | Phase 2 |
| Completed | Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disor NCT02502903 | Bioverativ, a Sanofi company | Phase 1 |